Activest Wealth Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
Activest Wealth Management's ALNY Position: Q3 2026 in Review
Activest Wealth Management reduced its Alnylam Pharmaceuticals (ALNY) stake by 95% in Q3 2026, selling an estimated $5.34K and leaving 1 share worth $247. The position accounts for ﹤0.01% of the portfolio, ranked #958.
Activest Wealth Management first reported a position in ALNY in Q4 2024 and has held it in 7 quarters since. The position peaked at $42.9K in Q4 2025. 730 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.
- Activest Wealth Management held 1 share of Alnylam Pharmaceuticals worth $247 as of Q3 2026.
- Activest Wealth Management sold 21 Alnylam Pharmaceuticals shares in Q3 2026, an estimated $5.34K.
- Alnylam Pharmaceuticals made up ﹤0.01% of Activest Wealth Management's portfolio in Q3 2026, its #958 holding.
- Activest Wealth Management first reported a position in Alnylam Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
- Activest Wealth Management's Alnylam Pharmaceuticals position peaked at $42.9K in Q4 2025.
- 730 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.
Based on Activest Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.